New insights into biomarkers and risk stratification to predict hepatocellular cancer

Li, Katrina, Mathew, Brandon, Saldanha, Ethan, Ghosh, Puja, Krainer, Adrian R, Dasarathy, Srinivasan, Huang, Hai, Xiang, Xiyan, Mishra, Lopa (April 2025) New insights into biomarkers and risk stratification to predict hepatocellular cancer. Molecular Medicine, 31 (1). p. 152. ISSN 1528-3658

PDF 10.1186.s10020-025-01194-6.pdf - Published Version Available under License Creative Commons Attribution. Download (2MB)

Abstract

Hepatocellular carcinoma (HCC) is the third major cause of cancer death worldwide, with more than a doubling of incidence over the past two decades in the United States. Yet, the survival rate remains less than 20%, often due to late diagnosis at advanced stages. Current HCC screening approaches are serum alpha-fetoprotein (AFP) testing and ultrasound (US) of cirrhotic patients. However, these remain suboptimal, particularly in the setting of underlying obesity and metabolic dysfunction-associated steatotic liver disease/steatohepatitis (MASLD/MASH), which are also rising in incidence. Therefore, there is an urgent need for novel biomarkers that can stratify risk and predict early diagnosis of HCC, which is curable. Advances in liver cancer biology, multi-omics technologies, artificial intelligence, and precision algorithms have facilitated the development of promising candidates, with several emerging from completed phase 2 and 3 clinical trials. This review highlights the performance of these novel biomarkers and algorithms from a mechanistic perspective and provides new insight into how pathological processes can be detected through blood-based biomarkers. Through human studies compiled with animal models and mechanistic insight in pathways such as the TGF-β pathway, the biological progression from chronic liver disease to cirrhosis and HCC can be delineated. This integrated approach with new biomarkers merit further validation to refine HCC screening and improve early detection and risk stratification.

Item Type:	Paper
Subjects:	diseases & disorders > cancer diseases & disorders diseases & disorders > cancer > cancer types > liver cancer diseases & disorders > cancer > cancer types
CSHL Authors:	Krainer, Adrian R.
Communities:	CSHL labs > Krainer lab
SWORD Depositor:	CSHL Elements
Depositing User:	CSHL Elements
Date:	23 April 2025
Date Deposited:	24 Apr 2025 15:08
Last Modified:	24 Apr 2025 15:08
Related URLs:	Publisher
URI:	https://repository.cshl.edu/id/eprint/41857

Actions (login required)

Administrator's edit/view item